Dr. Vineela Kasireddy, MD

Dr. Kasireddy practices at University Hospital (MU Health Care) in Columbia, Missouri.

Dr. Kasireddy's NPI, 1003256645, was assigned on June 27, 2013. Dr. Kasireddy holds Missouri license 2022000584.

Dr. Kasireddy's primary practice is University Hospital (MU Health Care), at 1 Hospital Dr, Columbia, MO 65201 in Boone County. The practice phone is (573) 882-4141.

Dr. Kasireddy's primary practice is University Hospital (MU Health Care) in Columbia, Missouri. Dr. Kasireddy is also affiliated with University Hospital. The medical group on file is University of Missouri Health Care. Dmand AI also links Dr. Kasireddy to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kasireddy practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kasireddy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kasireddy is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kasireddy's licenses on file in 2 states: Missouri and Pennsylvania.

CMS data shows 835 Medicare services from Dr. Kasireddy across 6 procedure codes in 2024, for 177 Medicare patients. Medicare paid $34,975 for them. Every service was in an office.

CMS counts 177 Medicare patients who saw Dr. Kasireddy in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kasireddy's median patient age at 72, with 63% women.

In 2024, Dr. Kasireddy wrote 930 Medicare Part D claims for 183 patients. 86% of them were for generic drugs. CMS names the drug for 635 of them, across 20 drugs with 11 or more claims each, at $538,462 in total drug cost. In 2023, CMS named 608 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kasireddy for performance year 2024, reported as part of a group. Dr. Kasireddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Kasireddy, published from 2017 to 2022. 2021 was the busiest year, with 5. Dr. Kasireddy has published most often in Cureus. Dr. Kasireddy's most frequent co-authors are Sushmita Khadka, MD, Arthur Ackerman Winer, MD and Fern Merrideth Anari, MD.

Dmand AI links Dr. Kasireddy to 3 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Rectal Diseases and Carcinoma, Bronchogenic. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 93 general payments to Dr. Kasireddy from 35 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Celgene Corporation paid the most, $171.